rs12918964

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000293.3(PHKB):​c.3121C>T​(p.Arg1041Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0106 in 1,518,908 control chromosomes in the GnomAD database, including 111 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1041Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0074 ( 6 hom., cov: 32)
Exomes 𝑓: 0.011 ( 105 hom. )

Consequence

PHKB
NM_000293.3 missense

Scores

3
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.718

Publications

12 publications found
Variant links:
Genes affected
PHKB (HGNC:8927): (phosphorylase kinase regulatory subunit beta) Phosphorylase kinase is a polymer of 16 subunits, four each of alpha, beta, gamma and delta. The alpha subunit includes the skeletal muscle and hepatic isoforms, encoded by two different genes. The beta subunit is the same in both the muscle and hepatic isoforms, encoded by this gene, which is a member of the phosphorylase b kinase regulatory subunit family. The gamma subunit also includes the skeletal muscle and hepatic isoforms, encoded by two different genes. The delta subunit is a calmodulin and can be encoded by three different genes. The gamma subunits contain the active site of the enzyme, whereas the alpha and beta subunits have regulatory functions controlled by phosphorylation. The delta subunit mediates the dependence of the enzyme on calcium concentration. Mutations in this gene cause glycogen storage disease type 9B, also known as phosphorylase kinase deficiency of liver and muscle. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene. Two pseudogenes have been found on chromosomes 14 and 20, respectively.[provided by RefSeq, Feb 2010]
PHKB Gene-Disease associations (from GenCC):
  • glycogen storage disease IXb
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0072407722).
BP6
Variant 16-47698565-C-T is Benign according to our data. Variant chr16-47698565-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 319360.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00736 (1043/141740) while in subpopulation NFE AF = 0.0128 (846/65928). AF 95% confidence interval is 0.0121. There are 6 homozygotes in GnomAd4. There are 470 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PHKBNM_000293.3 linkc.3121C>T p.Arg1041Trp missense_variant Exon 30 of 31 ENST00000323584.10 NP_000284.1 Q93100-1
PHKBNM_001363837.1 linkc.3121C>T p.Arg1041Trp missense_variant Exon 30 of 31 NP_001350766.1
PHKBNM_001031835.3 linkc.3100C>T p.Arg1034Trp missense_variant Exon 31 of 32 NP_001027005.1 Q93100-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PHKBENST00000323584.10 linkc.3121C>T p.Arg1041Trp missense_variant Exon 30 of 31 1 NM_000293.3 ENSP00000313504.5 Q93100-1

Frequencies

GnomAD3 genomes
AF:
0.00737
AC:
1044
AN:
141718
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00212
Gnomad AMI
AF:
0.0179
Gnomad AMR
AF:
0.00319
Gnomad ASJ
AF:
0.000593
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000684
Gnomad FIN
AF:
0.00532
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0128
Gnomad OTH
AF:
0.00509
GnomAD2 exomes
AF:
0.00590
AC:
1455
AN:
246562
AF XY:
0.00594
show subpopulations
Gnomad AFR exome
AF:
0.00205
Gnomad AMR exome
AF:
0.00293
Gnomad ASJ exome
AF:
0.000502
Gnomad EAS exome
AF:
0.0000548
Gnomad FIN exome
AF:
0.00451
Gnomad NFE exome
AF:
0.0106
Gnomad OTH exome
AF:
0.00483
GnomAD4 exome
AF:
0.0109
AC:
15071
AN:
1377168
Hom.:
105
Cov.:
31
AF XY:
0.0105
AC XY:
7206
AN XY:
687628
show subpopulations
African (AFR)
AF:
0.00186
AC:
58
AN:
31118
American (AMR)
AF:
0.00314
AC:
136
AN:
43290
Ashkenazi Jewish (ASJ)
AF:
0.000122
AC:
3
AN:
24512
East Asian (EAS)
AF:
0.0000823
AC:
3
AN:
36472
South Asian (SAS)
AF:
0.000499
AC:
42
AN:
84158
European-Finnish (FIN)
AF:
0.00458
AC:
227
AN:
49604
Middle Eastern (MID)
AF:
0.00136
AC:
7
AN:
5146
European-Non Finnish (NFE)
AF:
0.0133
AC:
13935
AN:
1046646
Other (OTH)
AF:
0.0117
AC:
660
AN:
56222
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.419
Heterozygous variant carriers
0
605
1210
1814
2419
3024
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
518
1036
1554
2072
2590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00736
AC:
1043
AN:
141740
Hom.:
6
Cov.:
32
AF XY:
0.00688
AC XY:
470
AN XY:
68314
show subpopulations
African (AFR)
AF:
0.00212
AC:
82
AN:
38768
American (AMR)
AF:
0.00318
AC:
45
AN:
14130
Ashkenazi Jewish (ASJ)
AF:
0.000593
AC:
2
AN:
3370
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4712
South Asian (SAS)
AF:
0.000687
AC:
3
AN:
4364
European-Finnish (FIN)
AF:
0.00532
AC:
39
AN:
7330
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
264
European-Non Finnish (NFE)
AF:
0.0128
AC:
846
AN:
65928
Other (OTH)
AF:
0.00505
AC:
10
AN:
1982
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
54
109
163
218
272
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00970
Hom.:
44
Bravo
AF:
0.00674
TwinsUK
AF:
0.0143
AC:
53
ALSPAC
AF:
0.0106
AC:
41
ESP6500AA
AF:
0.00318
AC:
14
ESP6500EA
AF:
0.0143
AC:
123
ExAC
AF:
0.00573
AC:
695
Asia WGS
AF:
0.00116
AC:
4
AN:
3474
EpiCase
AF:
0.0101
EpiControl
AF:
0.00946

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Glycogen storage disease IXb Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Dec 12, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PHKB: BP4, BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 10, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:1
Aug 10, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.26
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.14
.;.;T
Eigen
Benign
0.0019
Eigen_PC
Benign
0.047
FATHMM_MKL
Benign
0.71
D
LIST_S2
Benign
0.84
T;T;T
MetaRNN
Benign
0.0072
T;T;T
MetaSVM
Benign
-0.71
T
MutationAssessor
Uncertain
2.2
.;M;M
PhyloP100
0.72
PrimateAI
Benign
0.23
T
PROVEAN
Benign
-2.0
N;N;N
REVEL
Benign
0.22
Sift
Benign
0.041
D;D;D
Sift4G
Uncertain
0.012
D;D;D
Polyphen
0.99
D;.;P
Vest4
0.24
MVP
0.78
MPC
0.28
ClinPred
0.035
T
GERP RS
3.0
Varity_R
0.047
gMVP
0.37
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12918964; hg19: chr16-47732476; COSMIC: COSV54529126; API